Global Patent Index - EP 1071329 A4

EP 1071329 A4 2001-05-02 - METHODS AND COMPOSITIONS FOR TREATMENT OF AIDS-ASSOCIATED KAPOSI'S SARCOMA

Title (en)

METHODS AND COMPOSITIONS FOR TREATMENT OF AIDS-ASSOCIATED KAPOSI'S SARCOMA

Title (de)

VERFAHREN UND ZUSAMMENSETZUNGEN FÜR DIE BEHANDLUNG VON AIDS-BEDINGTEM KARPOSI-SARKOM

Title (fr)

PROCEDES ET COMPOSITIONS PERMETTANT DE TRAITER LE SARCOME DE KARPOSI ASSOCIE AU SIDA

Publication

EP 1071329 A4 (EN)

Application

EP 98913281 A

Priority

US 9806221 W

Abstract (en)

[origin: WO9965307A1] The present invention comprises methods and compositions for treating a human with AIDS-associated Kaposi's sarcoma. More specifically, the method comprises administration of a taxane composition over a 3 hour infusion schedule. Importantly, the compositions and methods of administration allows for reduction of side effects and reduces the symptoms of Kaposi's sarcoma.

IPC 1-7 (main, further and additional classification)

A01N 43/20; A61K 31/335; A61K 38/55; A61P 31/18

IPC 8 full level (invention and additional information)

A61K 45/00 (2006.01); A01N 43/20 (2006.01); A61K 31/337 (2006.01); A61K 31/70 (2006.01); A61K 45/06 (2006.01); A61P 35/00 (2006.01); A61P 37/04 (2006.01); A61P 43/00 (2006.01)

CPC (invention and additional information)

A61K 31/70 (2013.01); A61K 31/337 (2013.01); A61K 45/06 (2013.01)

Combination set (CPC)

A61K 31/70 + A61K 2300/00

Citation (search report)

  • [Y] BURDICK A E. ET AL: "Resolution of Kaposi s sarcoma associated with undetectable level of human Herpesvirus 8 DNA in a patient with AIDS after Protease Inhibitor Therapy", JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, vol. 37, no. 4, 1997, pages 648 - 649, XP000983556
  • [Y] CONANT M.A. ET AL: "Reduction of Kaposi s sarcoma lesions following treatment of AIDS with Ritonovir", AIDS, vol. 11, no. 10, - 1997, pages 1300 - 1301, XP000983605
  • [Y] VON ROENN J.: "Management of AIDS-associated Kaposi 's sarcoma: A multidisciplinary perspective.", ONCOLOGY, (1998) 12/2 SUPPL. 3 (9-24)., XP000983550
  • [Y] WELLES L. ET AL.: "Phase II Trial with dose titration of Paclitaxel for the therapy of human immunodeficiency virus-associated Kaposi s sarcoma.", JOURNAL OF CLINICAL ONCOLOGY, vol. 16, no. 3, 1998 - March 1998 (1998-03-01), pages 1112 - 1121, XP000983694
  • See also references of WO 9965307A1

Designated contracting state (EPC)

AT BE CH DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE

EPO simple patent family

WO 9965307 A1 19991223; AU 6787398 A 20000105; CA 2301665 A1 19991223; CN 1255041 A 20000531; EP 1071329 A1 20010131; EP 1071329 A4 20010502; JP 2002518297 A 20020625

INPADOC legal status


2003-04-16 [18D] APPLICATION DEEMED TO BE WITHDRAWN

- Effective date: 20021002

2001-05-02 [A4] DESPATCH OF SUPPLEMENTARY SEARCH REPORT

- Effective date: 20010321

2001-05-02 [AK] DESIGNATED CONTRACTING STATES:

- Kind Code of Ref Document: A4

- Designated State(s): AT BE CH DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE

2001-05-02 [RIC1] CLASSIFICATION (CORRECTION)

- Free text: 7A 01N 43/20 A, 7A 61K 31/335 B, 7A 61K 38/55 B, 7A 61P 31/18 B

2001-01-31 [17P] REQUEST FOR EXAMINATION FILED

- Effective date: 19991026

2001-01-31 [AK] DESIGNATED CONTRACTING STATES:

- Kind Code of Ref Document: A1

- Designated State(s): AT BE CH DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE